Mechanisms of endocannabinoid inactivation: Biochemistry and pharmacology

Journal of Pharmacology and Experimental Therapeutics

Volumn 298, Issue 1, 2001, Pages 7-14

  Giuffrida, Andrea ^a   Beltramo, Massimiliano ^b   Piomelli, Daniele ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Schering Plough Research Institute   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID RECEPTOR ANTAGONIST; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; PYRIDINE DERIVATIVE; RIMONABANT;

ATTENTION DEFICIT DISORDER; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

AMIDOHYDROLASES; ARACHIDONIC ACID; ARACHIDONIC ACIDS; BIOLOGICAL TRANSPORT; BRAIN; CANNABINOIDS; ENDOCANNABINOIDS; GLYCERIDES; PIPERIDINES; PYRAZOLES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034978249     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. (R)-Methanandamide: A chiral novel anandamide possessing higher potency and metabolic stability
2. The cloned rat hydrolytic enzyme responsible for the breakdown of anandamide also catalyzes its formation via the condensation of arachidonic acid and ethanolamine
3. Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid, 2-arachidonylglycerol
4. 2-receptor responses by an anandamide transport inhibitor
5. Functional role of high-affinity anandamide transport, as revealed by selective inhibition
6. Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells
7. Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes
8. Exceptionally potent inhibitors of fatty acid amide hydrolase: The enzyme responsible for degradation of endogenous oleamide and anandamide
9. Potentiation of anandamide hypotension by the transport inhibitor, AM404
10. A role for the endogenous cannabinoid system in the peripheral control of pain initiation
11. Inhibition of intestinal motility by anandamide, an endogenous cannabinoid
12. Cannabinoid modulation of intestinal propulsion in mice
13. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
14. Chemical characterization of a family brain lipids that induce sleep
15. Anandamide amidohydrolase activity in rat brain microsomes: Identification and partial characterization
16. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist
17. Production and physiological actions of anandamide in the vasculature of the rat kidney
18. Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor
19. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
20. Biosynthesis and inactivation of the endocannabinoid 2-arachidonylglycerol in circulating and tumoral macrophages
21. Formation and inactivation of endogenous cannabinoid anandamide in central neurons
22. A new perspective on cannabinoid signaling: Complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain
23. Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation
24. Molecular characterization of human and mouse fatty acid amide hydrolases
25. Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374)
26. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum
27. Elevated levels of anandamide after administration of the transport inhibitor, AM404
28. Quantification of bioactive acylethanolamides in rat plasma by electrospray mass spectrometry
29. Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide
30. Enzymes of porcine brain hydrolyzing 2-arachidonylglycerol, an endogenous ligand of cannabinoid receptors
31. Anandamide amidohydrolase reacting with 2-arachidonylglycerol, another cannabinoid receptor ligand
32. Localization of cannabinoid receptors in brain and periphery
33. Endocannabinoids and vascular function
34. Accumulation of N-arachidonylethanolamide (anandamide) into cerebellar granule cells occurs via facilitated diffusion
35. Structure-activity relationships among N-arachidonylethanolamine (anandamide) head group analogues for the anandamide transporter
36. Distribution of anandamide amidohydrolase in rat tissues with special reference to small intestine
37. Structure-activity relationships of anandamide, an endogenous cannabinoid ligand
38. Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase
39. Anandamide uptake by human endothelial cells and its regulation by nitric oxide
40. Anandamide activates human platelets through a pathway independent of the arachidonate cascade
41. Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage
42. Anandamide hydrolysis by human cells in culture and brain
43. Spinal cannabinoids are anti-allodynic in rats with persistent inflammation
44. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
45. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation
46. Treatment of Tourette syndrome with delta-9-tetrahydrocannabinol
47. Catabolism of N-acylethanolamine phospholipids by dog brain preparations
48. Fatty acid amide hydrolase competitively degrades bioactive amides and esters through a nonconventional catalytic mechanism
49. Chemical and mutagenic investigations of fatty acid amide hydrolase: Evidence for a family of serine hydrolases with distinct catalytic properties
50. Cannabinoid receptor ligands: Clinical and neuropharmacological considerations, relevant to future drug discovery and development
51. Structural determinants for recognition and translocation by the anandamide transporter
52. The endocannabinoid system as a target for therapeutic drugs
53. Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells
54. Behavioral effects of anandamide and the amidase inhibitor AM374
55. Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation
56. A sensitive endocannabinoid assay. The simultaneous analysis of N-acylethanolamines and 2-monoacylglycerols
57. Anandamide an endogenous activator of the vanilloid receptor
58. A second endogenous cannabinoid that modulates long-term potentiation
59. 2-Arachidonylglycerol: A possible endogenous cannabinoid receptor ligand in brain
60. Vanilloid (Capsaicin) receptors and mechanisms
61. Fatty acid amide hydrolase, the degradative enzyme for anandamide and oleamide, has selective distribution in neurons within the rat central nervous system
62. An acid amidase hydrolyzing anandamide as an endogenous ligand for cannabinoid receptors
63. Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide
64. Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro
65. Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock
66. Cardiovascular actions of cannabinoids and their generation during shock
67. Pain modulation by release of the endogenous cannabinoid anandamide